U.S. Food and Drug Administration leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny.

Participants come out to walk and support the Out of the Darkness Walk in Chicago in September 2024. (Photo by Barry Brecheisen/Getty...